These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14502489)

  • 21. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.
    Weill N; Rognan D
    J Chem Inf Model; 2009 Apr; 49(4):1049-62. PubMed ID: 19301874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New tools for G-protein coupled receptor (GPCR) drug discovery: combination of baculoviral expression system and solid state NMR.
    Ratnala VR
    Biotechnol Lett; 2006 Jun; 28(11):767-78. PubMed ID: 16786240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classifying G-protein coupled receptors with bagging classification tree.
    Huang Y; Cai J; Ji L; Li Y
    Comput Biol Chem; 2004 Oct; 28(4):275-80. PubMed ID: 15548454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-based structural hypotheses for virtual screening.
    Jain AN
    J Med Chem; 2004 Feb; 47(4):947-61. PubMed ID: 14761196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase.
    Sadat Hayatshahi SH; Abdolmaleki P; Ghiasi M; Safarian S
    FEBS Lett; 2007 Feb; 581(3):506-14. PubMed ID: 17250831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a gene family screening library targeting G-protein coupled receptors.
    Lamb ML; Bradley EK; Beaton G; Bondy SS; Castellino AJ; Gibbons PA; Suto MJ; Grootenhuis PD
    J Mol Graph Model; 2004 Sep; 23(1):15-21. PubMed ID: 15331050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling anti-Trypanosoma cruzi activity of N-oxide containing heterocycles.
    Boiani M; Cerecetto H; Gonzalez M; Gasteiger J
    J Chem Inf Model; 2008 Jan; 48(1):213-9. PubMed ID: 18163603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
    Pinheiro JR; Bitencourt M; da Cunha EF; Ramalho TC; Freitas MP
    Bioorg Med Chem; 2008 Feb; 16(4):1683-90. PubMed ID: 18053727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism-based network-like similarity graphs reveal relationships between different types of receptor ligands and structural changes that determine agonistic, inverse-agonistic, and antagonistic effects.
    Iyer P; Stumpfe D; Bajorath J
    J Chem Inf Model; 2011 Jun; 51(6):1281-6. PubMed ID: 21548655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the predictive power of unsupervised visualization techniques to improve the identification of GPCR-focused compound libraries.
    von Korff M; Hilpert K
    J Chem Inf Model; 2006; 46(4):1580-7. PubMed ID: 16859289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
    Hu L; Chen G; Chau RM
    J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action.
    Vilar S; Santana L; Uriarte E
    J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.